In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Cholesterol Tests are carried out to assess the risks of cardiovascular disease, including heart attack or stroke. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cholesterol tests devices market, including market shares of different players within Finland. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the cholesterol tests market in Finland was Siemens followed by Danaher, Abbott Laboratories, F. Hoffmann-La Roche, QuidelOrtho, Merck, Thermo Fisher Scientific, Sekisui Chemical and Sinocare.
This market comprises of High-Density Lipoprotein (HDL) Cholesterol Tests, Low-Density Lipoprotein (LDL) Cholesterol Tests, Total Cholesterol Tests, and Multi-parameter Cholesterol Tests
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the cholesterol tests devices market within Finland was expected to be over $5m in 2022.
For the latest complete market share analysis of cholesterol tests device market in Finland, buy the report here.